1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Mixed Results For Spironolactone In Heart Failure With Preserved Ejection … – Forbes

February 26, 2013Organ Failureadmin

Mixed Results For Spironolactone In Heart Failure With Preserved Ejection ...
Forbes
Although the mineralocorticoid receptor antagonists (MRAs) spironolactone and eplerenone (Inspra, Pfizer) have been shown to be beneficial in patients with heart failure (HF) with reduced ejection fraction (EF), their role in heart failure patients ...
Heart Failure Drug May Not Ease Symptoms in SomeWebMD
Long-Term Use of Medication Does Not Improve Symptoms for Heart Failure ...Science Daily (press release)
Spironolactone disappoints in preserved-EF heart failure: Aldo-DHF in printTheHeart.Org
Family Practice News Digital Network -MedPage Today
all 6 news articles »

Post navigation

← Erasing Death – Huffington Post (blog) Bone marrow drive in Carmel for former resident – The Journal News | LoHud.com →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos